Combined anticoagulation and antiplatelet therapy for high-risk patients with atrial fibrillation: a systematic review

Research output: Contribution to journalArticle

Colleges, School and Institutes

Abstract

Previous research suggests uncertainty whether or not there is any additional benefit in adding antiplatelet therapy (APT) to anticoagulation therapy (ACT) in patients with high-risk atrial fibrillation (AF) in terms of reduction in vascular events, including stroke. The existing guidelines acknowledge an increased risk of bleeding associated with such a strategy; however, there is no consensus on the treatment pathway.

Details

Original languageEnglish
Pages (from-to)1-188
Number of pages188
JournalHealth Technology Assessment
Volume17
Issue number30
Publication statusPublished - Jul 2013